Holding(s) in Company

Date : 09/07/2009 @ 5:03AM
Source : UK Regulatory (RNS & others)
Stock : Osmetech (OMH)
Quote : 1.9  0.0 (0.00%) @ 3:43AM
<< BackQuote Chart

 

Holding(s) in Company

 

TIDMOMH 
 
RNS Number : 6142Y 
Osmetech PLC 
07 September 2009 
 
? 
7 September 2009 
Disclosure of Significant Shareholdings 
 
Osmetech PLC ('Osmetech' or 'the Company') (AIM:OMH) announces that it was 
notified on 4 September that, following a disposal of 7,000,000 shares in the 
Company, Jeffrey Taylor's total interest in Osmetech shares is now 66,819,243 
shares representing 5.79% of the current issued share capital. 
Jeffrey Taylor's interest is held as follows: 
+------------+------------+----------+ 
| Registered | Number     | % of     | 
| Owner      | of         | issued   | 
|            | ordinary   | share    | 
|            | shares     | capital  | 
+------------+------------+----------+ 
| Crown      | 56,701,936 | 4.91%    | 
| Taylor     |            |          | 
| Money      |            |          | 
| Purchase   |            |          | 
| Pension    |            |          | 
| Plan       |            |          | 
+------------+------------+----------+ 
| Bankers    | 10,117,307 | 0.88%    | 
| Union      |            |          | 
| Trust      |            |          | 
+------------+------------+----------+ 
| Total      | 66,819,243 | 5.79%    | 
+------------+------------+----------+ 
The total number of issued ordinary 0.1p shares is 1,153,642,510. Osmetech does 
not hold any ordinary shares in Treasury. Therefore, the total number of voting 
rights in Osmetech is 1,153,642,510. 
For further information: 
 
+--------------------------------+-----------------------------------------------+ 
| Osmetech plc:                  | +44 (0) 20 7849 6027                          | 
+--------------------------------+-----------------------------------------------+ 
| David Sandilands, Finance      |                                               | 
| Director                       |                                               | 
+--------------------------------+-----------------------------------------------+ 
|                                |                                               | 
+--------------------------------+-----------------------------------------------+ 
| Madano Partnership:            | +44 (0) 207 593 4000                          | 
+--------------------------------+-----------------------------------------------+ 
| Mark Way                       |                                               | 
+--------------------------------+-----------------------------------------------+ 
|                                |                                               | 
+--------------------------------+-----------------------------------------------+ 
| Canaccord Adams Limited:       | +44 (0) 20 7050 6500                          | 
+--------------------------------+-----------------------------------------------+ 
| Robert Finlay                  |                                               | 
+--------------------------------+-----------------------------------------------+ 
| Henry Fitzgerald-O'Connor      |                                               | 
+--------------------------------+-----------------------------------------------+ 
 
 
 
This information is provided by RNS 
            The company news service from the London Stock Exchange 
   END 
 
 HOLSSFSUWSUSESU 
 


Osmetech Historical Chart Osmetech Intraday Chart  
Period


LSE and PLUS quotes are live. NYSE and AMEX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.
The Spread Bet Centre :: The CFD Centre :: Financial Glossary :: Forex Rates, Charts & News
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions :: Contact Us :: Request an Exchange :: Affiliate Scheme
Copyright 1999-2010 ADVFN PLC. Copyright Notice & Privacy Policy :: Privacy Policy :: Investment Warning :: Advertise with us :: Data accreditations :: Investor Relations :: Press office :: Jobs
34 site:2us 100321 18:22